These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10234533)

  • 1. Ocular tolerance of preservatives on the murine cornea.
    Furrer P; Mayer JM; Plazonnet B; Gurny R
    Eur J Pharm Biopharm; 1999 Mar; 47(2):105-12. PubMed ID: 10234533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants.
    Furrer P; Plazonnet B; Mayer JM; Gurny R
    Int J Pharm; 2000 Oct; 207(1-2):89-98. PubMed ID: 11036234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-hydroxymethylglycinate with EDTA is an efficient eye drop preservative with very low toxicity: an in vitro comparative study.
    Cristaldi M; Olivieri M; Lupo G; Anfuso CD; Pezzino S; Rusciano D
    Cutan Ocul Toxicol; 2018 Mar; 37(1):71-76. PubMed ID: 28658977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic effects of benzalkonium chloride and chlorobutanol on human corneal epithelial cells in vitro.
    Tripathi BJ; Tripathi RC
    Lens Eye Toxic Res; 1989; 6(3):395-403. PubMed ID: 2486935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study.
    Labbé A; Pauly A; Liang H; Brignole-Baudouin F; Martin C; Warnet JM; Baudouin C
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):267-78. PubMed ID: 16910868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular tolerance of preservatives and alternatives.
    Furrer P; Mayer JM; Gurny R
    Eur J Pharm Biopharm; 2002 May; 53(3):263-80. PubMed ID: 11976014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of acute corneal barrier change induced by topically applied preservatives using corneal transepithelial electric resistance in vivo.
    Kusano M; Uematsu M; Kumagami T; Sasaki H; Kitaoka T
    Cornea; 2010 Jan; 29(1):80-5. PubMed ID: 19770721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New tools for the evaluation of toxic ocular surface changes in the rat.
    Pauly A; Brignole-Baudouin F; Labbé A; Liang H; Warnet JM; Baudouin C
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5473-83. PubMed ID: 18055795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal epithelial permeability after instillation of ophthalmic solutions containing local anaesthetics and preservatives.
    Ramselaar JA; Boot JP; van Haeringen NJ; van Best JA; Oosterhuis JA
    Curr Eye Res; 1988 Sep; 7(9):947-50. PubMed ID: 2460291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of corneal thickness after the instillation of topical anesthetics: proparacaine versus oxybuprocaine.
    Nam SM; Lee HK; Kim EK; Seo KY
    Cornea; 2006 Jan; 25(1):51-4. PubMed ID: 16331042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity of cosmetic preservatives on human ocular surface and adnexal cells.
    Chen X; Sullivan DA; Sullivan AG; Kam WR; Liu Y
    Exp Eye Res; 2018 May; 170():188-197. PubMed ID: 29486163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ophthalmic preservatives as absorption promoters for ocular drug delivery.
    Sasaki H; Nagano T; Yamamura K; Nishida K; Nakamura J
    J Pharm Pharmacol; 1995 Sep; 47(9):703-7. PubMed ID: 8583378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural changes to corneal stromal cells due to ophthalmic preservatives.
    Collin HB
    Acta Ophthalmol (Copenh); 1986 Feb; 64(1):72-8. PubMed ID: 3083641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of artificial tears on corneal epithelium in dry-eye syndrome.
    Göbbels M; Spitznas M
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(2):139-41. PubMed ID: 2721982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopharmaceutical test of ocular irritation in the mouse.
    Etter JC; Wildhaber A
    Food Chem Toxicol; 1985 Feb; 23(2):321-3. PubMed ID: 4040085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells.
    Ammar DA; Noecker RJ; Kahook MY
    Adv Ther; 2011 Jun; 28(6):501-10. PubMed ID: 21603985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very-high-frequency ultrasound corneal imaging as a new tool for early diagnosis of ocular surface toxicity in rabbits treated with a preserved glaucoma drug.
    Denoyer A; Ossant F; Arbeille B; Fetissof F; Patat F; Pourcelot L; Pisella PJ
    Ophthalmic Res; 2008 Oct; 40(6):298-308. PubMed ID: 18506111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal thickness values before and after oxybuprocaine 0.4% eye drops.
    Asensio I; Rahhal SM; Alonso L; Palanca-Sanfrancisco JM; Sanchis-Gimeno JA
    Cornea; 2003 Aug; 22(6):527-32. PubMed ID: 12883345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal and conjunctival changes caused by commonly used glaucoma medications.
    Noecker RJ; Herrygers LA; Anwaruddin R
    Cornea; 2004 Jul; 23(5):490-6. PubMed ID: 15220734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells.
    Ayaki M; Yaguchi S; Iwasawa A; Koide R
    Clin Exp Ophthalmol; 2008 Aug; 36(6):553-9. PubMed ID: 18954319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.